Investment Confidence Among Laboratory Decision MakersThe laboratory industry enjoyed several years of robust growth from ...
decision makers are fairly confident that their laboratories will be sufficiently funded to maintain properwork environmen...
Upcoming SlideShare
Loading in …5
×

Investment confidence among laboratory decision makers

104 views

Published on

Published in: Technology, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
104
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Investment confidence among laboratory decision makers

  1. 1. Investment Confidence Among Laboratory Decision MakersThe laboratory industry enjoyed several years of robust growth from the late 1990s until 2003. Thecombination of record research and development (R&D) investments by the biopharmaceutical industrywith the doubling of the United States National Institutes of Health (NIH) budget allowed continualdouble-digit growth rates. While laboratory investments were dampened from 2003 through 2008,growth rates remained relatively stable in the mid-to-high single digit range.During the latter half of 2008, the laboratory industry embarked on a rollercoaster ride with multipleups and downs. The economic downturn had a tremendous impact on the laboratory industry withacross-the-board budget cuts. Facing impending doom after the downfall in the fourth quarter of 2008,the industry was revived with the 2009 United States American Recovery and Reinvestment Act (ARRA)containing $xx.x billion dedicated to the NIH to be spent immediately in 2009 and 2010. However, withfunding slow to be distributed to laboratories, the industry saw little benefit until the fourth quarter of2009, resulting in the first market contraction in over a decade.Report Details:Published: February 2012No. of Pages: 46Price: US $ 10000The year 2010 was marked by a huge bounce-back: academic researchers were flush with AARA fundsand the industrial sector rebounded from its 2009 purchasing freezes. The combination of stimulusdollars and pent-up demand resulted in an exceptionally strong year for the laboratory industry. Whileconsolidation among biopharmaceutical companies remained a major obstacle for growth, by the end of2010 the general industry consensus was that the market had returned to a state of normalcy.Accordingly, 2011 started off strong with residual impact from stimulus dollars and the generaleconomic recovery. Come the fall months, though, the market began to soften with laboratory hiringfreezes and deterioration across most purchasing budgets. Despite drastic changes, the overall marketremained relatively flat compared to 2010. If there was any growth, it was low: around x percentglobally. In more mature regional markets, like in the United States, Europe, and Japan, growth rateswere certainly lower. Despite a recovery, industry growth did not return to pre-recessionary levels.The study investigates investment decisions of healthcare-related laboratory decision makers. It showsthat 2011 was tumultuous for the laboratory industry. In comparison, the outlook for 2012 looks onlyslightly positive. In particular, laboratory decision makers generally expect their funding conditions toeither remain the same or minimally improve. Nonetheless, with this year still kicking-off, there arereasons to believe that 2012 has some good things in store for the laboratory industry. Laboratory
  2. 2. decision makers are fairly confident that their laboratories will be sufficiently funded to maintain properwork environments and acquire the necessary technology to reach the research objectives.Request a Sample for or Inquire before buying the report @http://www.reportsnreports.com/reports/152826-investment-confidence-among-laboratory-decision-makers.htmlContact:TX, Dallas North - Dominion Plaza,17304, Preston Road,Suite 800, Dallas 75252.+ 1 888 391 5441sales@reportsandreports.comConnect With Us:

×